Article

Plant-produced RBD and cocktail-based vaccine candidates are highly effective against SARS-CoV-2, independently of its emerging variants

2022-04-08

Abstract excerpt

SARS-CoV-2 is a novel and highly pathogenic coronavirus, which has caused an outbreak in Wuhan City, China, in 2019 and then spread rapidly throughout the world. Although several COVID-19 vaccines are currently available for mass immunization, they are less effective against emerging SARS-CoV-2 variants, especially the Omicron (B.1.1.529). Recently, we successfully produced receptor-binding domain (RBD) variants o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 70793c3f-76c5-5206-96a2-9ab6d7f93adc
DOI: 10.1101/2022.04.07.487347

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Plant-produced RBD and cocktail-based vaccine candidates are highly effective against SARS-CoV-2, independently of its emerging variantsDOI 10.1101/2022.04.07.487347Read

Transient production of Receptor-Binding Domain of SARS-CoV-2 in Nicotiana benthamiana plants induces specific antibodies in immunized miceSemantic proximity Read

Phase 1 trial of a Candidate Recombinant Virus-Like Particle Vaccine for Covid-19 Disease Produced in PlantsSemantic proximity Read

Immunogenicity of adjuvanted plant-produced SARS-CoV-2 Beta spike VLP vaccine in New Zealand white rabbitsSemantic proximity Read

A Novel Double Mosaic Virus-like Particle-Based Vaccine against SARS-CoV-2 Incorporates Both Receptor Binding Motif (RBM) and Fusion DomainSemantic proximity Read

Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodiesSemantic proximity Read

Efficacy and Safety of a Plant-Based Virus-Like Particle Vaccine for COVID-19 Adjuvanted with AS03Semantic proximity Read

Neutralizing antibody-independent immunity to SARS-CoV-2 in hamsters and hACE-2 transgenic mice immunized with a RBD/Nucleocapsid fusion proteinSemantic proximity Read

Plant-Derived Recombinant Vaccines against Zoonotic VirusesSemantic proximity Read

Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like ParticlesSemantic proximity Read

Vaccine and vaccination as a part of human life: in view of Covid-19Semantic proximity Read

The edible tomato COVID-19 vaccine, TOMAVAC, induces neutralising IgGsSemantic proximity Read

Plant-Based Virus-Like Particle (VLP) Vaccines Against Influenza and Hepatitis VirusesSemantic proximity Read